Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (NASDAQ: ALGN) is a global medical device company best known for the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The ALGN news feed on Stock Titan aggregates company announcements, clinical product updates, financial disclosures, and professional education highlights directly relevant to investors and dental professionals.
Recent news shows Align focusing on digital orthodontics and restorative dentistry, with updates on innovations such as ClinCheck® Live Plan for automated Invisalign treatment planning, new features for iTero Digital Solutions, and expanded availability of Invisalign System options like mandibular advancement with occlusal blocks for Class II correction in growing patients. News items also cover Align’s participation in major dental congresses, including the Greater New York Dental Meeting, where the company showcases its Align™ Digital Platform and related tools.
Investors following ALGN news will see regular earnings announcements and outlook updates, including quarterly revenue, clear aligner volumes, imaging systems and CAD/CAM services performance, and commentary on geographic trends. SEC-related press releases, such as those tied to Form 8-K filings on financial results or leadership changes, also appear in the news flow.
Align’s communications further highlight research, education, and community programs, including its Annual Research Award Program for university-based dental research and partnerships with organizations like the Canadian Foundation for the Advancement of Orthodontics through Smiles4Canada. For users tracking ALGN, this news page offers a centralized view of product launches, clinical innovations, financial milestones, and corporate initiatives that shape the company’s role in digital dentistry.
Align Technology, Inc. (NASDAQ: ALGN) has announced the Invisalign ChangeMakers program, providing $5,000 to 100 young leaders for community projects. Launched in partnership with National 4-H Council, the initiative recognizes teens aged 13-19 making a positive impact. Winners were chosen based on applications received from January to March 2021. Celebrated during a virtual ceremony on July 10, 2021, some recipients included youth creating health and educational initiatives. Align emphasizes the importance of community involvement and youth empowerment.
Align Technology (NASDAQ: ALGN) has launched its first limited-edition product, the Charli D’Amelio x Invisalign® Aligner Case, designed in collaboration with social media star Charli D’Amelio. This exclusive aligner case features a pink exterior, lavender interior, and Charli's mantra, "All Smiles Here." Priced at $24.99, it will be available at the official Invisalign store. Align's milestone of treating over 10.2 million patients highlights the brand's impact in digital orthodontics, improving patient outcomes.
Summary not available.
Align Technology has launched the new iTero Workflow 2.0 software, enhancing practice efficiency with features like faster scanning, improved visualization, and advanced patient communication tools. The software, set to be available in Q3 2021, streamlines Invisalign case submissions by allowing intraoral color scan images instead of traditional photos. The iTero Element 5D Plus imaging system will support these upgrades, aiming to boost clinical diagnosis and patient engagement for better treatment acceptance.
Align Technology (Nasdaq: ALGN) has awarded $250,000 in research grants as part of its eleventh Annual Research Award Program, aimed at advancing dental and orthodontic treatments. Since 2010, the company has funded over $2.0 million in research, receiving numerous applications from global universities. The awarded studies cover diverse topics in orthodontics and dentistry, highlighting Align's commitment to innovation and improving oral health outcomes.
Align Technology (Nasdaq: ALGN) announced its participation in several upcoming financial conferences, where key executives will present details about the company and its offerings. The presentations will be webcast live from Align's Investor Relations website, with archived replays available for three months. Notable events include the William Blair Growth Stock Conference on June 1, Stifel Jaws & Paws Conference on June 2, Jefferies Healthcare Conference on June 3, Goldman Sachs Healthcare Conference on June 9, and the Nasdaq Investor Conference on June 16.
Align Technology, Inc. (Nasdaq: ALGN) has announced a new accelerated stock repurchase agreement with Goldman Sachs to buy back $100 million of its common stock. This repurchase is part of Align's $1.0 billion stock buyback program initiated on May 13, 2021. Under the ASR, Align will initially acquire about 143,000 shares, with the final total dependent on the stock's volume-weighted average price. The transaction is anticipated to conclude by August 2021 and will utilize Align's cash reserves, which stood at $1.1 billion as of March 31, 2021.
Align Technology (Nasdaq: ALGN) announced the launch of new consumer campaigns aimed at increasing demand for Invisalign treatment among teens and young adults. The multi-touch campaign builds on previous efforts, leveraging data analytics and engaging digital content through influencers. Align invests over $250 million annually in brand awareness to connect with potential patients. Currently, over 10 million consumers have utilized Invisalign for orthodontic treatment. The campaign will target various markets globally, starting in the US before expanding to regions including Australia, the UK, and Brazil.
Align Technology (ALGN) has authorized a new stock repurchase program, allowing the company to buy back up to $1.0 billion of its common stock over the next three years. This decision reflects the strength of Align's balance sheet and its commitment to returning capital to shareholders. The new program follows a $600 million repurchase authorization from May 2018, which included a $100 million accelerated stock repurchase transaction. Align currently has approximately 79.1 million shares outstanding and $1.1 billion in cash and cash equivalents.
Align Technology supports the updated policy statement from the General Dental Council (GDC), highlighting the necessity of a physical examination before orthodontic treatments. This ensures thorough assessment of patients' oral health and mandates that patients are informed about the dental professionals responsible for their care. Julie Coletti, the company’s legal officer, commended the GDC for its role in upholding dental standards in the UK, emphasizing that proper orthodontic treatment must be delivered by qualified professionals following in-person evaluations.